The effect of low temperature aged garlic extract on cognitive functio
- Conditions
- Mild Cognitive Impairment
- Registration Number
- JPRN-UMIN000038247
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 51
Not provided
1.Those who are receiving the medicines that affect the evaluation of this study; i.e. donepezil hydrochloride, galantamine hydrobromide, memantine hydrochloride, rivastigmine, and zonisamide. 2.Those who are taking supplement for improving cognitive function; i.e. ginkgo biloba extract, EPA / DHA, plasmalogen, phosphatidylserine / choline, anthocyanin, GABA, arachidonic acid, seryltyrosine, histidine, ferulic acid, and garden angelica. 3.Those who have history of epilepsy or brain disease. 4.Those who have been diagnosed with a malignant tumor or have a history of severe liver damage, kidney damage or heart disease. 5.Those who consume a large amount of alcohol; i.e. 60g or more of alcohol per day. 6.Those who may develop allergies to test food ingredients. 7.At screening test, the test results are classified as treatment required by the Judgment Categorydetermined by the Japan Medical Dock Association (April 1, 2018 revision, December 14, 2018 partial change). 8.Those who have been judged by a doctor to be unable to complete the study or to have a significant risk to the subject due to abnormal medical or mental conditions. 9.Those who are participting in aother clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function (MMSE): 12 weeks after the start of administration
- Secondary Outcome Measures
Name Time Method Quality of sleep (PSQI, JESS, AIS-J) Health related QOL (SF-36) Blood, urine: 12 weeks after the start of administration